El Salvador vs Iraq: The number of people with susceptibility test result for rifampicin
El Salvador
26.6
in 2021
Iraq
29.8
in 2021
El Salvador rank
135th
Iraq rank
133rd
The number of people with susceptibility test result for rifampicin over time
- El Salvador
- Iraq
How they compare
Iraq currently reports 29.8 against 26.6 in El Salvador, a difference of 3.2.
That makes Iraq's figure about 1.1 times El Salvador's.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was Iraq ahead.
El Salvador ranks 135th and Iraq ranks 133rd of 146 countries.
Across the 2 decades both report, El Salvador averaged higher in 1 and Iraq in 1.
Head to head by decade
| Decade | El Salvador | Iraq | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 34.13 | 89.53 | 55.4 | Iraq |
| 2020s | 33.06 | 18.21 | 14.86 | El Salvador |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, El Salvador or Iraq?
- Iraq, at 29.8 against 26.6 in El Salvador as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between El Salvador and Iraq?
- 3.2, with Iraq ahead.
- How many years of comparable data are there for El Salvador and Iraq?
- 5 years are reported by both, from 2017 to 2021.
- How do El Salvador and Iraq rank globally for the number of people with susceptibility test result for rifampicin?
- El Salvador ranks 135th and Iraq ranks 133rd of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.